000144733 001__ 144733
000144733 005__ 20240229112635.0
000144733 0247_ $$2doi$$a10.1155/2019/3516973
000144733 0247_ $$2pmid$$apmid:31485223
000144733 0247_ $$2pmc$$apmc:PMC6702834
000144733 0247_ $$2ISSN$$a1687-8450
000144733 0247_ $$2ISSN$$a1687-8469
000144733 0247_ $$2altmetric$$aaltmetric:68954614
000144733 037__ $$aDKFZ-2019-02165
000144733 041__ $$aeng
000144733 082__ $$a610
000144733 1001_ $$aSun, Hanxue$$b0
000144733 245__ $$aThe Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.
000144733 260__ $$aNew York, NY$$bHindawi Publ. Corp.$$c2019
000144733 3367_ $$2DRIVER$$aarticle
000144733 3367_ $$2DataCite$$aOutput Types/Journal article
000144733 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1568202107_656
000144733 3367_ $$2BibTeX$$aARTICLE
000144733 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144733 3367_ $$00$$2EndNote$$aJournal Article
000144733 520__ $$aPancreatic cancer-initiating cells (PaCIC) express CD44v6 and Tspan8. A knockdown (kd) of these markers hinders the metastatic capacity, which can be rescued, if the cells are exposed to CIC-exosomes (TEX). Additional evidence that CD44v6 regulates Tspan8 expression prompted us to explore the impact of these PaCIC markers on nonmetastatic PaCa and PaCIC-TEX. We performed proteome, miRNA, and mRNA deep sequencing analyses on wild-type, CD44v6kd, and Tspan8kd human PaCIC and TEX. Database comparative analyses were controlled by qRT-PCR, Western blot, flow cytometry, and confocal microscopy. Transcriptome analysis of CD44 versus CD44v6 coimmunoprecipitating proteins in cells and TEX revealed that Tspan8, several signal-transducing molecules including RTK, EMT-related transcription factors, and proteins engaged in mRNA processing selectively associate with CD44v6 and that the membrane-attached CD44 intracytoplasmic tail supports Tspan8 and NOTCH transcription. Deep sequencing uncovered a CD44v6 contribution to miRNA processing. Due to the association of CD44v6 with Tspan8 in internalization prone tetraspanin-enriched membrane domains (TEM) and the engagement of Tspan8 in exosome biogenesis, most CD44v6-dependent changes were transferred into TEX such that the input of CD44v6 to TEX activities becomes largely waved in both a CD44v6kd and a Tspan8kd. Few differences between CD44v6kd- and Tspan8kd-TEX rely on CD44v6 being also recovered in non-TEM derived TEX, highlighting distinct TEX delivery from individual cells that jointly account for TEX-promoted target modulation. This leads us to propose a model in which CD44v6 strongly supports tumor progression by cooperating with signaling molecules, altering transcription of key molecules, and through its association with the mRNA processing machinery. The association of CD44v6 with Tspan8, which plays a crucial role in vesicle biogenesis, promotes metastases by transferring CD44v6 activities into TEM and TEM-independently derived TEX. Further investigations of the lead position of CD44v6 in shifting metastasis-promoting activities into CIC-TEX may offer a means of targeting TEX-CD44v6 in therapeutic applications.
000144733 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000144733 588__ $$aDataset connected to CrossRef, PubMed,
000144733 7001_ $$aRana, Sanyukta$$b1
000144733 7001_ $$aWang, Zhe$$b2
000144733 7001_ $$aZhao, Kun$$b3
000144733 7001_ $$0P:(DE-He78)38b33779833838a98c2a241ce465fb07$$aSchnölzer, Martina$$b4$$udkfz
000144733 7001_ $$aProvaznik, Jan$$b5
000144733 7001_ $$aHackert, Thilo$$b6
000144733 7001_ $$00000-0001-5127-6195$$aLv, Qingjie$$b7
000144733 7001_ $$aZöller, Margot$$b8
000144733 773__ $$0PERI:(DE-600)2461349-6$$a10.1155/2019/3516973$$gVol. 2019, p. 1 - 24$$p3516973$$tJournal of oncology$$v2019$$x1687-8469$$y2019
000144733 909CO $$ooai:inrepo02.dkfz.de:144733$$pVDB
000144733 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)38b33779833838a98c2a241ce465fb07$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000144733 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000144733 9141_ $$y2019
000144733 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ ONCOL : 2017
000144733 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144733 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144733 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144733 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000144733 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000144733 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000144733 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000144733 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000144733 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000144733 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000144733 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000144733 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000144733 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000144733 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000144733 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000144733 9201_ $$0I:(DE-He78)B100-20160331$$kB100$$lFunktionelle Proteomanalyse$$x0
000144733 980__ $$ajournal
000144733 980__ $$aVDB
000144733 980__ $$aI:(DE-He78)B100-20160331
000144733 980__ $$aUNRESTRICTED